ZA958597B - Benzo-fused compounds - Google Patents

Benzo-fused compounds

Info

Publication number
ZA958597B
ZA958597B ZA958597A ZA958597A ZA958597B ZA 958597 B ZA958597 B ZA 958597B ZA 958597 A ZA958597 A ZA 958597A ZA 958597 A ZA958597 A ZA 958597A ZA 958597 B ZA958597 B ZA 958597B
Authority
ZA
South Africa
Prior art keywords
benzo
fused compounds
fused
compounds
Prior art date
Application number
ZA958597A
Other languages
English (en)
Inventor
Mark Anthony Dombroski
Kevin Koch
Anthony Daniel Piscopio
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA958597B publication Critical patent/ZA958597B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA958597A 1994-10-13 1995-10-12 Benzo-fused compounds ZA958597B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32287694A 1994-10-13 1994-10-13

Publications (1)

Publication Number Publication Date
ZA958597B true ZA958597B (en) 1997-04-14

Family

ID=23256829

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958597A ZA958597B (en) 1994-10-13 1995-10-12 Benzo-fused compounds

Country Status (23)

Country Link
US (2) US6051601A (fr)
EP (1) EP0785930A1 (fr)
JP (1) JP2983295B2 (fr)
KR (1) KR100232341B1 (fr)
CN (1) CN1160399A (fr)
AU (1) AU696890B2 (fr)
BR (1) BR9504385A (fr)
CA (1) CA2201742A1 (fr)
CO (1) CO4480024A1 (fr)
CZ (1) CZ111797A3 (fr)
FI (1) FI971524A0 (fr)
HU (1) HUT77515A (fr)
IL (1) IL115529A0 (fr)
MX (1) MX9702731A (fr)
NO (1) NO971672L (fr)
NZ (1) NZ285156A (fr)
PE (1) PE10897A1 (fr)
PL (1) PL319688A1 (fr)
RU (1) RU2128655C1 (fr)
TR (1) TR199501270A2 (fr)
TW (1) TW304941B (fr)
WO (1) WO1996011920A1 (fr)
ZA (1) ZA958597B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100339164B1 (ko) * 1996-09-16 2002-06-01 디. 제이. 우드, 스피겔 알렌 제이 치환된 크로만올 유도체의 제조 방법 및 이에 사용되는 중간체
JP2001509143A (ja) * 1996-12-13 2001-07-10 イーライ・リリー・アンド・カンパニー 大脳病巣性卒中のためのロイコトリエンアンタゴニスト
IL128731A0 (en) * 1998-03-12 2000-01-31 Pfizer Prod Inc Method of preventing allograft rejection
EP0963755A3 (fr) * 1998-04-16 2001-03-14 Pfizer Products Inc. Utilisation des benzopyranes pour la prévention de rejets de graiffes
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
JP2004518685A (ja) * 2001-01-30 2004-06-24 ファイザー・プロダクツ・インク クロマニル安息香酸の調製方法
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
IL165220A0 (en) 2002-06-19 2005-12-18 Biovitrum Ab Novel compounds, their use and preparation
RU2007101510A (ru) * 2004-07-22 2008-08-27 Фармаци Корпорейшн (US) Композиции для лечения воспаления и боли с использованием комбинации селективного ингибитора сох-2 и антагониста рецептора ltb4
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
JP2008523145A (ja) 2004-12-13 2008-07-03 イーライ リリー アンド カンパニー リポキシゲナーゼ阻害剤としてのスピロ誘導体
BRPI0520097A2 (pt) 2005-02-25 2009-08-25 Lilly Co Eli composto ou estereoisÈmeros únicos, misturas de estereoisÈmeros, ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
WO2007134149A2 (fr) 2006-05-11 2007-11-22 Janssen Pharmaceutica N.V. Dérivés de 3,4-dihydro-2h-benzo[1,4]oxazine et thiazine en tant qu'inhibiteurs de cetp
CA2651942A1 (fr) 2006-05-11 2008-07-03 Janssen Pharmaceutica N.V. Derives de 1,2,3,4-tetrahydro-quinoline en tant qu'inhibiteurs de la cetp
JP4907746B2 (ja) 2008-09-11 2012-04-04 ファイザー・インク ヘテロアリールアミド誘導体およびグルコキナーゼ活性化因子としてのその使用
RS52903B (en) 2009-03-11 2014-02-28 Pfizer Inc BENZOFURANIL DERIVATIVES FOR USE AS GLUCOKINASE INHIBITORS
EP2814494B1 (fr) 2012-02-14 2019-08-21 Children's Hospital Medical Center Utilisation d'inhibiteurs à petites molécules ciblant l'interaction entre rac gtpase et p67 (phox)
CN102920692A (zh) * 2012-10-25 2013-02-13 中国人民解放军第二军医大学 (e)-2-(1-羟基-4-环己酮)乙基咖啡酸酯在制备防治类风湿关节炎的药物中的应用
CN107531660A (zh) 2015-03-13 2018-01-02 福马治疗股份有限公司 作为HDAC8抑制剂的α‑肉桂酰胺化合物和组合物
WO2017040963A1 (fr) 2015-09-03 2017-03-09 Forma Therapeutics, Inc. Inhibiteurs de hdac8 bicyclique [6,6] fusionnée
EP3383869B1 (fr) 2015-11-30 2023-06-28 Merck Sharp & Dohme LLC Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
WO2017095724A1 (fr) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
WO2017095722A1 (fr) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
US10370368B2 (en) 2015-11-30 2019-08-06 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
WO2018071687A1 (fr) * 2016-10-13 2018-04-19 The Regents Of The University Of California Méthodes de traitement du prurit

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (fr) * 1987-01-12 1993-07-20 Darrel M. Gapinski Agents antiinflammatoires
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
CA2019335C (fr) * 1989-06-27 2000-08-01 Mitoshi Konno Acides phenylakan(en)oiques
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5051438A (en) * 1990-05-16 1991-09-24 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
WO1993015066A1 (fr) * 1992-01-23 1993-08-05 Pfizer Inc. Benzopyranne et antagonistes du ltb4 apparentes

Also Published As

Publication number Publication date
TW304941B (fr) 1997-05-11
NZ285156A (en) 1999-01-28
US6051601A (en) 2000-04-18
WO1996011920A1 (fr) 1996-04-25
CO4480024A1 (es) 1997-07-09
PE10897A1 (es) 1997-04-21
RU2128655C1 (ru) 1999-04-10
US6133286A (en) 2000-10-17
KR100232341B1 (ko) 2000-07-01
NO971672L (no) 1997-06-11
CA2201742A1 (fr) 1996-04-25
JP2983295B2 (ja) 1999-11-29
BR9504385A (pt) 1997-05-27
IL115529A0 (en) 1996-01-19
FI971524A (fi) 1997-04-11
TR199501270A2 (tr) 1996-06-21
EP0785930A1 (fr) 1997-07-30
FI971524A0 (fi) 1997-04-11
MX9702731A (es) 1997-06-28
NO971672D0 (no) 1997-04-11
CZ111797A3 (cs) 1998-07-15
HUT77515A (hu) 1998-05-28
JPH09512035A (ja) 1997-12-02
CN1160399A (zh) 1997-09-24
AU2416795A (en) 1996-05-06
PL319688A1 (en) 1997-08-18
AU696890B2 (en) 1998-09-24
KR970706270A (ko) 1997-11-03

Similar Documents

Publication Publication Date Title
GB9407812D0 (en) Compounds
GB9414193D0 (en) Compounds
GB9414208D0 (en) Compounds
IL115529A0 (en) Benzo-fused compounds
GB9404706D0 (en) Compounds
GB9406043D0 (en) Compounds
GB9409921D0 (en) Compounds
GB9407435D0 (en) Compounds
GB9417938D0 (en) Compounds
GB9403199D0 (en) Compounds
GB9402197D0 (en) Compounds
GB9400413D0 (en) Compounds
GB9402041D0 (en) Compounds
GB9410035D0 (en) Compounds
GB9402603D0 (en) Compounds
GB2296241B (en) Compounds
GB9402196D0 (en) Compounds
GB9401609D0 (en) Compounds
GB9414783D0 (en) Compounds
GB9414784D0 (en) Compounds
GB9410205D0 (en) Compounds
GB9413508D0 (en) Compounds
GB9413500D0 (en) Compounds
GB9414801D0 (en) Compounds
GB9413498D0 (en) Compounds